Research programme : neuropsychiatric disorder therapeutics - Alto Neuroscience
Alternative Names: 100'S SERIES NOVEL COMBINATIONS; 100'S SERIES NOVEL COMBINATIONS C-AMP pathwayLatest Information Update: 02 Feb 2024
At a glance
- Originator Alto Neuroscience
- Class Behavioural disorder therapies
- Mechanism of Action Cyclic AMP receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Neurological disorders; Psychiatric disorders
Most Recent Events
- 02 Jan 2024 Preclinical trials in Neurological disorders in USA (unspecified route) (Alto Neuroscience pipeline, January 2024)
- 02 Jan 2024 Preclinical trials in Psychiatric disorders in USA (unspecified route) (Alto Neuroscience pipeline, January 2024)